Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

MBOT

Microbot Medical Inc

Sep 15 • 04:00PM ET

3.42

-0.63 -15.56 %

Healthcare • Medical Instruments & Supplies • USA • NASD

Peers: ISRG TMO MDT SYK BDX EW ZBH ABT GMED WAT

| Held by: VTI VXF IWC AVSC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.57	Insider Own	1.11%	Shs Outstand	45.55M	Perf Week	-24.00%
Market Cap	155.78M	Forward P/E	22.80	EPS next Y	0.15	Insider Trans	0.00%	Shs Float	45.04M	Perf Month	9.27%
Enterprise Value	123.20M	PEG	-	EPS next Q	-0.08	Inst Own	14.00%	Short Float	16.61%	Perf Quarter	46.15%
Income	-12.71M	P/S	-	EPS this Y	58.90%	Inst Trans	52.49%	Short Ratio	2.34	Perf Half Y	122.08%
Sales	0.00M	P/B	4.28	EPS next Y	150.00%	ROA	-62.65%	Short Interest	7.48M	Perf YTD	205.36%
Book/sh	0.80	P/C	4.76	EPS next 5Y	-	ROE	-69.80%	52W High	4.67 -26.77%	Perf Year	268.69%
Cash/sh	0.72	P/FCF	-	EPS past 3/5Y	22.83% 15.51%	ROIC	-41.80%	52W Low	0.85 302.35%	Perf 3Y	-34.61%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	12.90% 11.68%	Perf 5Y	-48.18%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	29.39%	Oper. Margin	-	ATR (14)	0.43	Perf 10Y	-99.61%
Dividend Ex-Date	-	Quick Ratio	12.06	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	48.25	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	12.06	EPS Q/Q	42.23%	SMA20	-8.08%	Beta	1.30	Target Price	12.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	9.50%	Rel Volume	3.60	Prev Close	4.05
Employees	21	LT Debt/Eq	0.00	Earnings	Aug 12	SMA200	54.27%	Avg Volume	3.20M	Price	3.42
IPO	Mar 25, 1992	Option/Short	Yes / Yes	EPS/Sales Surpr.	-25.00% -	Trades		Volume	11,517,308	Change	-15.56%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-13-20	Reiterated	H.C. Wainwright	Buy	$12 → $26
Dec-24-19	Reiterated	H.C. Wainwright	Buy	$10 → $12
Jan-31-18	Initiated	Ladenburg Thalmann	Buy	$1.75

Today 08:00AM	Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds (GlobeNewswire) -15.56%
Sep-09-25 01:25PM	Microbot Shares Rise on FDA Clearance for LIBERTY Robotic System (Zacks) -14.44%
08:28AM	REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference (GlobeNewswire)
01:30AM	Microbot receives 510(k) clearance for endovascular robot (MedTech Dive)
Sep-08-25 08:28AM	Microbot Medical Receives FDA 510(k) Clearance for Its LIBERTY Endovascular Robotic System (GlobeNewswire) +22.95%
10:30AM	Loading…
Aug-25-25 10:30AM	BC-Most Active Stocks (Associated Press Finance) +8.05%
Aug-21-25 01:33PM	Microbot Shares Rise as New U.S. Patent Expands LIBERTY System Market (Zacks) +7.55%
Aug-20-25 08:30AM	Microbot Medical Granted U.S. Patent that Significantly Expands Potential Market Applications (GlobeNewswire) +7.12%
Aug-08-25 08:00AM	DIH Appoints Scott R. Burell to DIH Holding US, Inc. Board of Directors (GlobeNewswire) +5.82%
Aug-06-25 06:46AM	Microbot Medical secures grant for endovascular robotic system (Medical Device Network)
Aug-05-25 08:30AM	Microbot Medical Receives Non-Dilutive Grant to Enhance Operational Capabilities (GlobeNewswire) +8.68%
Jul-22-25 08:30AM	Microbot Medical Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales (GlobeNewswire)
Jul-09-25 07:20AM	Microbot Medical Secures China Patent for LIBERTY System, Eyes Q3 2025 US Launch (Insider Monkey)
Jul-08-25 08:30AM	Microbot Medical to Open Inaugural Endovascular Robotics Session at the Society of Robotic Surgery Annual Meeting (GlobeNewswire)
Jun-30-25 08:30AM	Microbot Medical Added to the Russell Microcap Index (GlobeNewswire)
08:30AM	Loading…
Jun-17-25 08:30AM	Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China (GlobeNewswire)
Jun-12-25 12:00PM	Microbot Medical (MBOT) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Jun-09-25 09:05AM	Beat the Market the Zacks Way: Ryanair, Monster Beverage, Ulta Beauty in Focus (Zacks) -11.39%
08:30AM	Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY Endovascular Robotic System (GlobeNewswire)
Jun-05-25 08:30AM	Microbot Medical Selected for Preliminary Inclusion to Russell Microcap Index (GlobeNewswire)
Apr-23-25 08:30AM	Microbot Medical Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers (GlobeNewswire)
Apr-18-25 03:26PM	Is Microbot Medical Inc. (MBOT) the Best Rising Penny Stock to Buy According to Analysts? (Insider Monkey)
Apr-15-25 09:00AM	Global Robotic Exoskeleton Market Size Expected to Reach $30 Billion By 2032 as A.I. Influence Disrupts the Industry (GlobeNewswire) +11.84%
Apr-10-25 09:00AM	Microbot posts pivotal surgical robot data; GE Healthcare hires Patient Care Solutions leader (MedTech Dive) +8.48%
Apr-09-25 08:30AM	Microbot Medical Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY Endovascular Robotic System (GlobeNewswire) +18.71%
Apr-01-25 08:30AM	REMINDER: Microbot Medical Announces Data from the Companys ACCESS-PVI trial will be Presented via Podium Presentation at Society of Interventional Radiology Annual Meeting (GlobeNewswire)
Mar-04-25 08:30AM	Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY Endovascular Robotic System (GlobeNewswire)
Feb-25-25 08:30AM	Robotic Telesurgery Data from Collaboration with Corewell Health Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting (GlobeNewswire)
Feb-11-25 06:15PM	Microbot Medical Closes $13 Million Registered Direct Offering (GlobeNewswire) -12.12% +5.91%
Feb-10-25 08:00AM	Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules (GlobeNewswire) -9.41%
08:30AM	Loading…
Feb-04-25 08:30AM	Microbot Medical Announces Late-Breaking Abstract Acceptance at the Society of Interventional Radiology Annual Meeting (GlobeNewswire) +13.81%
Feb-03-25 07:07PM	Why Microbot Medical Inc. (MBOT) Is Skyrocketing So Far In 2025 (Insider Monkey)
Jan-21-25 08:30AM	Microbot Medical Strengthens Its Management Team in Support of the Anticipated Commercial Launch of LIBERTY (GlobeNewswire) +10.98%
Jan-13-25 08:30AM	Microbot Medical Strengthens Its Commercial Capabilities with the Addition of David J. Wilson to the Board of Directors (GlobeNewswire) -7.77%
Jan-10-25 10:25AM	Microbot Medical Closes $8.6 Million Registered Direct Offering (GlobeNewswire)
Jan-09-25 08:22AM	Microbot Medical prices 3.79M shares at $2.27 in registered direct offering (TipRanks)
Jan-08-25 08:00AM	Microbot Medical Announces $8.6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules (GlobeNewswire) -33.92%
Jan-07-25 04:15PM	Microbot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM Facility (GlobeNewswire)
Jan-06-25 08:00AM	Microbot Medical Announces $7 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules (GlobeNewswire) +32.71%
Dec-30-24 08:30AM	Microbot Medical Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY (GlobeNewswire) +6.31%
Dec-11-24 05:00AM	Microbot Medical seeks FDA clearance for endovascular robotic system (Medical Device Network)
Dec-10-24 10:18AM	Microbot Medical CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access (GlobeNewswire)
08:00AM	Microbot Medical Announces FDA Submission for the Commercialization of the LIBERTY Endovascular Robotic System (GlobeNewswire)
Dec-03-24 08:45AM	Global Medical Service Robotics Market Project to Exceed $20 Billion in 2024 with Additional Growth Expected (GlobeNewswire)
Oct-15-24 11:21AM	Microbot eyes FDA application for surgical robot after completing pivotal trial (Medical Device Network)
08:38AM	Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY during 2Q 2025 (GlobeNewswire)
Sep-30-24 08:30AM	Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up (GlobeNewswire)
Sep-17-24 08:30AM	Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System (GlobeNewswire)
Aug-29-24 05:32AM	Microbot Medical advances Liberty Robotic System telesurgery innovation (Medical Device Network)
Aug-23-24 11:59AM	Microbot Medical (MBOT) Inks New Phase 2 Agreement for LIBERTY (Zacks)
Aug-22-24 08:30AM	Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY Endovascular Robotic System (GlobeNewswire) -6.25%
Aug-19-24 11:01AM	Microbot Medical (MBOT) Gets Quality Certification for its System (Zacks)
Aug-13-24 08:30AM	Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization (GlobeNewswire)
Aug-05-24 11:29AM	Microbot Medical (MBOT) Inks Deal to Test Autonomous Robotics (Zacks)
Aug-02-24 06:52AM	Microbot and Emory University to advance endovascular robotic system (Medical Device Network) -5.19%
Aug-01-24 08:30AM	Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY Endovascular Robotic Surgical System (GlobeNewswire)
Jul-18-24 08:30AM	Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center (GlobeNewswire)
Jul-11-24 01:47PM	Microbot Medical (MBOT) Progresses in Its Human Clinical Trial (Zacks)
Jul-09-24 08:30AM	Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial (GlobeNewswire)
Jul-08-24 08:20AM	Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial (GlobeNewswire)
Jul-05-24 11:48AM	Microbot Medical (MBOT) Inks Agreement to Begin LIBERTY Trial (Zacks)
08:13AM	Microbot secures second site for Liberty endovascular robot trial (Medical Device Network)
Jul-04-24 01:49PM	Microbot (MBOT) Inks a New Agreement to Begin Trial on LIBERTY (Zacks)
Jul-03-24 08:20AM	Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial (GlobeNewswire) +6.06%
Jun-26-24 11:14AM	Transforming surgery: Microbot Medical and Boston hospital collaborate on Liberty Surgical Robot trials (Medical Device Network)
Jun-21-24 06:53AM	Microbot partners with Boston Hospital to trial Liberty surgical robot (Medical Device Network)
Jun-20-24 08:25AM	Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial (GlobeNewswire)
Jun-17-24 08:30AM	Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial (GlobeNewswire)
Jun-04-24 04:20PM	Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules (GlobeNewswire) -17.39%
06:26AM	Microbots LIBERTY robotic system secures FDA approval for pivotal trial (Medical Device Network)
Jun-03-24 12:11PM	Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules (GlobeNewswire) +38.00%
08:20AM	Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial (GlobeNewswire)
May-15-24 11:53PM	MBOT Stock Earnings: Microbot Medical Meets EPS for Q1 2024 (InvestorPlace)
Apr-29-24 08:30AM	Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health (GlobeNewswire) +7.84%
Apr-15-24 08:30AM	Microbot Medical Shares Status Following Recent Geopolitical Events (GlobeNewswire)
Mar-27-24 10:53PM	MBOT Stock Earnings: Microbot Medical Misses EPS for Q4 2023 (InvestorPlace) +6.96%
Feb-07-24 10:08AM	Microbot Medical (MBOT) Files IDE to Start Human Clinical Study (Zacks)
Feb-05-24 07:30AM	Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US (GlobeNewswire)
Jan-30-24 07:20AM	Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters (GlobeNewswire) -5.38%
Jan-18-24 07:20AM	Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study (GlobeNewswire) +6.35%
Jan-03-24 10:12AM	Microbot Medical (MBOT) Announces Positive GLP Study Results (Zacks)
Dec-29-23 08:00AM	Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules (GlobeNewswire) -20.00%
Dec-28-23 07:30AM	Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met (GlobeNewswire) +55.30%
Dec-14-23 08:15AM	Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY Endovascular Robotic Surgical System for Telerobotic (GlobeNewswire)
Dec-10-23 02:31PM	3 Stocks at the Forefront of Medical Robotics (InvestorPlace)
Dec-07-23 08:00AM	Microbot Medical Announces the Successful Completion of Its GLP Pivotal Pre-Clinical Study, a Critical Milestone for Its IDE submission to Commence Human Clinical Study (GlobeNewswire)
Nov-21-23 09:12AM	Microbot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as its New Chief Medical Officer in Anticipation of Its Clinical, Regulatory and Commercial Activities (GlobeNewswire)
Nov-13-23 08:30AM	Microbot Medical Successfully Completed Integral Part of the Verification and Validation Process (GlobeNewswire)
Nov-08-23 09:10AM	Microbot Medical Granted Registered Trademark from The U.S. Patent and Trademark Office (GlobeNewswire) +8.70%
Oct-31-23 08:25AM	Microbot Medical Reveals Successful Short Term Follow Up Outcomes from its Pivotal Pre-Clinical Study (GlobeNewswire) +6.19%
Oct-24-23 08:19AM	Microbot Medical Received Confirmation for the Commencement of Its CE Mark Approval Process During the First Half of 2024 (GlobeNewswire)
Oct-19-23 08:20AM	Microbot Medical Announces Grant of Summary Judgment in its Favor and Dismissal of Counterclaim Against Company (GlobeNewswire) -7.53%
Oct-17-23 09:28AM	Microbot Medical Announces Successful Initial Outcomes from Its Pivotal Pre-Clinical Study with the LIBERTY Robotic Surgical System (GlobeNewswire) +14.96%
Sep-27-23 08:30AM	Microbot Medical Engages CRO to Support its Upcoming U.S. Pivotal Clinical Trial (GlobeNewswire)
Sep-08-23 10:02AM	Microbot Medical Gains Global Recognition; Professor Vincent Vidal to Present an Abstract on The LIBERTY® Robotic Surgical System at CIRSE 2023 (GlobeNewswire)
Aug-15-23 08:30AM	Microbot Medical Boosts Manufacturing and Commercialization Capabilities for its Robotic Surgical System (GlobeNewswire)
Aug-10-23 08:30AM	Microbot Medical Strengthens Its Position Among US Interventional Radiologists by Appointing Professor Francois H. Cornelis to Its Scientific Advisory Board (GlobeNewswire)
Jul-25-23 09:23AM	Microbot Medical Engaging with a Leading Notified Body to Advance CE Mark for Sales in Europe (GlobeNewswire)
Jul-11-23 08:30AM	Microbot Medical Expands its Physician Support with the Addition of Leading Italian Interventional Radiologist Irene Bargellini, M.D., to its Scientific Advisory Board (GlobeNewswire)
Jun-29-23 08:30AM	Microbot Medical Successfully Completes an Extensive Pre-Clinical Study Performed in the US (GlobeNewswire)

Microbot Medical, Inc. is a pre-clinical medical device company engaged in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The firm carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope, provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Hingham, MA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MBOT

Microbot Medical Inc

Upgrade your FINVIZ experience